Ginkgo bioworks announces participation in morgan stanley 21st annual global healthcare conference

Boston , sept. 6, 2023 /prnewswire/ -- ginkgo bioworks holdings, inc. (nyse: dna, "ginkgo"), which is building the leading platform for cell programming and biosecurity, announced today that anna marie wagner, senior vice president of corporate development, is scheduled to participate in a fireside chat at the morgan stanley 21st annual global healthcare conference on wednesday, september 13 at 12:55 p.m.
DNA Ratings Summary
DNA Quant Ranking